Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.

Gravity Diagnostics provides testing for toxicology, pharmacogenetics, infectious and upper respiratory diseases, blood diagnostics, and COVID-19.

The digital pathology software developer is raising funding that would help it to increase its head count and support its Aiosyn Mitosis Breast application.

The diagnostics startup is developing a testing platform that uses digital imaging and signal processing for pathogen identification and susceptibility determination.

Last week, readers were most interested in a story about BD's plan to separate its Biosciences and Diagnostics Solutions business by the end of 2026.